The utility of remdesivir in SARS-CoV-2: A single tertiary care center experience from a developing country

Background: Remdesivir is a monophosphoramidate prodrug of an adenosine analog, and it has a broad-spectrum antiviral activity against paramyxoviruses, flaviviruses, and coronaviruses. Remdesivir is associated with decreased hospital stay and improved outcomes in coronavirus- disease 2019 (COVID-19)...

Full description

Bibliographic Details
Main Authors: Muhammad Irfan Malik, Sardar Al Fareed Zafar, Muna Malik, Fabiha Qayyum, Iqra Akram, Ammarah Arshad, Khalid Waheed, Jodat Saleem, Abdul Jabbar, Muhammad Junaid Tahir, Zohaib Yousaf
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Exploratory Research in Clinical and Social Pharmacy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667276622000063